€10.38
0.38% today
Madrid, Aug 12, 05:35 pm CET
ISIN
ES0157097017
Symbol
ALM

Almirall Stock price

€10.38
-0.64 5.81% 1M
+1.28 14.00% 6M
+2.15 26.05% YTD
+1.46 16.37% 1Y
+0.56 5.70% 3Y
+0.61 6.24% 5Y
-7.24 41.08% 10Y
-3.89 27.27% 20Y
Madrid, Closing price Tue, Aug 12 2025
-0.04 0.38%
ISIN
ES0157097017
Symbol
ALM
Industry

Key metrics

Basic
Market capitalization
€2.2b
Enterprise Value
€2.2b
Net debt
positive
Cash
€374.4m
Shares outstanding
-
Valuation (TTM | estimate)
P/E
65.1 | 34.1
P/S
1.4 | 2.0
EV/Sales
1.4 | 1.9
EV/FCF
92.0
P/B
1.5
Dividends
DPS
€0.18
Yield 1Y | 5Y
1.8% | 1.8%
Growth 1Y | 5Y
0.0% | -1.5%
Payout 1Y | 3Y
368.0% | -461.7%
Increased
0 Years
Financials (TTM | estimate)
Revenue
€1.6b | €1.1b
EBITDA
€302.6m | €226.6m
EBIT
€94.1m | €87.5m
Net Income
€34.7m | -
Free Cash Flow
€23.7m
Growth (TTM | estimate)
Revenue
13.2% | 13.4%
EBITDA
21.8% | 20.1%
EBIT
51.7% | 76.4%
Net Income
233.1% | -
Free Cash Flow
120.6%
Margin (TTM | estimate)
Gross
74.0%
EBITDA
19.4% | 20.3%
EBIT
6.0%
Net
2.2% | -
Free Cash Flow
1.5%
Financial Health
Equity Ratio
62.1%
Return on Equity
0.7%
ROCE
-
ROIC
-
Debt/Equity
-
More
EPS
€0.2
FCF per Share
-
Short interest
-
Employees
2k
Rev per Employee
€490.0k
Show more

Is Almirall a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Almirall Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Almirall forecast:

12x Buy
80%
3x Hold
20%

Analyst Opinions

15 Analysts have issued a Almirall forecast:

Buy
80%
Hold
20%

Financial data from Almirall

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
1,564 1,564
13% 13%
100%
- Direct Costs 407 407
8% 8%
26%
1,157 1,157
15% 15%
74%
- Selling and Administrative Expenses 489 489
17% 17%
31%
- Research and Development Expense 158 158
24% 24%
10%
303 303
22% 22%
19%
- Depreciation and Amortization 209 209
12% 12%
13%
EBIT (Operating Income) EBIT 94 94
52% 52%
6%
Net Profit 35 35
233% 233%
2%

In millions EUR.

Don't miss a Thing! We will send you all news about Almirall directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Almirall SA is a global biopharmaceutical company, which is focused on skin health. It engages in the development, manufacture, storage, commercialization and sale of pharmaceutical and cosmetic products, as well as of the raw materials used in production. The firm operates through the following segments: Marketing through Own Network, Marketing by Licensees, Research and Development Activity, Therapeutic Area of Dermatology in the United States, and Corporate Management and Results not Allocated Assigned to Other Segments. Its products include treatments for respiratory, autoimmune, dermatological, and gastrointestinal diseases. The company was founded in 1943 and is headquartered in Barcelona, Spain.

Head office Spain
CEO Carlos Piqué
Employees 2,026
Founded 1995
Website www.almirall.es

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today